Meritain Health policies

Search Meritain Health's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

43 policies name 96415, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Meritain Health policies
PolicyDetailsCodesSource
0957-Calaspargase Pegol-mknl (Asparlas)0957 · Commercial2Original policy ↗
1069-Axatilimab-csfr (Niktimvo)1069 · Commercial3Original policy ↗
1074-Cosibelimab-ipdl (Unloxcyt)1074 · Commercial3Original policy ↗
1076-Zenocutuzumab-zbco (Bizengri)1076 · Commercial3Original policy ↗
0998-Tisotumab Vedotin-tftv (Tivdak)0998 · Commercial5Original policy ↗
0794-Ofatumumab (Arzerra)0794 · Commercial6Original policy ↗
1068-Afamitresgene Autoleucel (Tecelra)1068 · Commercial6Original policy ↗
1064-Crovalimab-akkz (PiaSky)1064 · Commercial7Original policy ↗
1071-Zolbetuximab-clzb (Vyloy)1071 · Commercial7Original policy ↗
1072-Obecabtagene Autoleucel (Aucatzyl)1072 · Commercial7Original policy ↗
1078-Datopotamab Deruxtecan-dlnk (Datroway)1078 · Commercial7Original policy ↗
1053-Lovotibeglogene Autotemcel (Lyfgenia)1053 · Commercial8Original policy ↗
0956-Docetaxel0956 · Commercial9Original policy ↗
1057-Tislelizumab-jsgr (Tevimbra)1057 · Commercial9Original policy ↗
1080-Penpulimab-kcqx1080 · Commercial9Original policy ↗
1036-Glofitamab-gxbm (Columvi)1036 · Commercial10Original policy ↗
1049-Toripalimab-tpzi (Loqtorzi)1049 · Commercial11Original policy ↗
1089-Linvoseltamab-gcpt (Lynozyfic)1089 · Commercial13Original policy ↗
Cabazitaxel (Jevtana)0806 · Commercial13Original policy ↗
0815-Ipilimumab (Yervoy)0815 · Commercial14Original policy ↗
0969-Isatuximab-irfc (Sarclisa)0969 · Commercial14Original policy ↗
1056-Lifileucel (Amtagvi)1056 · Commercial14Original policy ↗
1048-Mirikizumab-mrkz (Omvoh)1048 · Commercial15Original policy ↗
ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP)0780 · Commercial15Original policy ↗
Betibeglogene Autotemcel (Zynteglo)1016 · Commercial18Original policy ↗
0940-Mogamulizumab-kpkc (Poteligeo)0940 · Commercial19Original policy ↗
0876-Temozolomide (Temodar) Injection0876 · Commercial21Original policy ↗
Ixabepilone (Ixempra)0869 · Commercial22Original policy ↗
0675-Bortezomib Products0675 · Commercial23Original policy ↗
Retifanlimab-dlwr (Zynyz)1030 · Commercial23Original policy ↗
0883-Ramucirumab (Cyramza)0883 · Commercial24Original policy ↗
1075-Zanidatamab-hrii (Ziihera)1075 · Commercial30Original policy ↗
0867-Clofarabine0867 · Commercial32Original policy ↗
0875-Bendamustine Products0875 · Commercial34Original policy ↗
0955-Polatuzumab vedotin-piiq (Polivy)0955 · Commercial34Original policy ↗
Pemetrexed Products0687 · Commercial35Original policy ↗
0905-Secukinumab (Cosentyx)0905 · Commercial39Original policy ↗
Atezolizumab (Tecentriq) and Atezolizumab and Hyaluronidase-tqjs (Tecentriq Hybreza)0909 · Commercial46Original policy ↗
1102-Marnetegragene Autotemcel (Kresladi)1102 · Commercial48Original policy ↗
0877-Obinutuzumab (Gazyva)0877 · Commercial52Original policy ↗
0978-Lurbinectedin (Zepzelca)0978 · Commercial53Original policy ↗
0419-Graves' Ophthalmopathy Treatments0419 · Commercial62Original policy ↗
0890-Pembrolizumab Products (Keytruda and Keytruda Qlex)0890 · Commercial82Original policy ↗

Back to Meritain Health

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.